Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma.

Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC. · 2012

Read Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. by Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3282707.txt.

Introduction

Shannon Kidd and colleagues traced where the support cells inside tumors actually come from, in this 2012 paper in PLoS ONE. Fast-growing tumors recruit an entourage of non-cancerous cells that supply scaffolding, signals, and blood vessels, but the origins of that stroma were unclear. Using multicolored tissue transplants in mice with ovarian and breast tumors, the team measured each source's contribution cell type by cell type.

Most tumor-associated fibroblasts of the two kinds tracked came from mesenchymal stem cells resident in the bone marrow. In contrast, most of the vascular and fibrovascular stroma, the vessel-lining cells, pericytes, and contractile myofibroblasts, arrived from neighboring fat tissue. Tumors, the authors conclude, draw their building crews from multiple sources in a systematic, selective way, assigning different jobs to different suppliers.

Catalog record

CREATORKidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3282707

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma By Shannon Kidd, Erika Spaeth, Keri Watson, Jared Burks, Hongbo Lu, Ann Klopp, Michael Andreeff, Frank C. Marini, Pranela Rameshwar Published in: PLoS ONE DOI: 10.1371/journal.pone.0030563 ABSTRACT To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, α-SMA+ myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner. INTRODUCTION Constituents of the tumor microenvironment can arise from two major avenues: recruitment from nearby local tissue or systemic recruitment from distant tissue via circulation. Though constitution will vary from tumor to tumor, very little is definitively understood about the composition and origin of the host-derived cellular milieu found within the various tumor microenvironments. The most accessible option for tumor cells engaged in stromal cell recruitment is to exploit resources in close proximity to the site of tumor development. Dependent upon anatomical location, these tissues are often rich sources of fibroblasts, pericytes and vascular cells, as all cell types are critical for normal tissue function as well. Work by Udagawa et al. investigated the local cellular contribution to the tumor microenvironment by transplanting skin from a ubiquitously expressing green fluorescent protein (GFP)-expressing mouse and establishing tumors in the subcutaneous space beneath the engrafted skin [1]. Their findings suggest most of the tumor CD31+ vessels are recruited from cells within the nearby GFP+ tissue using either a murine syngeneic lung carcinoma or a xenogeneic osteosarcoma models. Additionally, studies focusing on fibrosis leading to cancer development have identified activated tissue resident cells responsible for excessive extracellular matrix (ECM) production, such as pancreatic stellate cells in pancreatitis that induce progression to pancreatic cancer [2] or peribronchiolar and perivascular adventitial lung fibroblasts that lead from lung fibrosis to lung cancer development [3]. Though not as easily accessible as local tissue, accumulating evidence has been presented suggesting recruitment from more distant cell sources, such as bone marrow. In cases of rapid tumor development, local cells may not be capable or in sufficient numbers to meet expanding growth demands. Additionally, as tumor vascular networks expand, access to systemically circulating cells in the blood supply increases concurrently. Accordingly, many findings have implicated extensive bone marrow contribution to the tumor microenvironment. Both bone marrow and adipose derived endothelial and mesenchymal progenitor cells have been isolated, cultured and injected back into mice to show that they possess both tumor tropic and tumor promoting capacity [4]–[8]. Furthermore, several studies have addressed the contribution of bone marrow derived cells to the tumor microenvironment utilizing transgenic mouse models [9], and human bone marrow transplant patient tumor samples [10]. The aforementioned studies suggest that bone marrow derived cells contributed to less than 20% of the stroma found in the tumor microenvironment, therefore, in our study, we sought to address the origin(s) of the remaining percentage of tumor associated stroma. As hematopoietic cells, all immune cells originate from the bone marrow, and the extensive contribution of immune cells in tumors such as macrophages and lymphocytes has been well documented [11]–[13]. In addition, our group recently demonstrated that bone marrow derived mesenchyme contributes to vascular and fibroblastic structures within the tumor microenvironment [7], [14]. Although these results are likely to be dependent on tumor type and experimental conditions, evidence from us and others clearly present several roles for non-immune bone marrow derived cells in the tumor microenvironment. Additional evidence for bone marrow originating circulating populations contributing to tumor stroma is provided in a few studies that report the existence of a circulating bone marrow derived endothelial progenitor cells (EPCs) capable of contributing 10–50% tumor associated endothelial cells in certain animal models [15]–[18]. Next, bone-marrow derived α-SMA+ myofibroblasts have been cited to contribute between 0–30% of stromal isolated fibroblasts within various tumor contexts [9], [19]–[21]. Finally, recent publications have proposed a bone marrow origin for pericytes within the tumor vasculature [22]–[26]. These above example suggest that bone marrow derived cells can contribute to multiple stromal compartments in the tumor microenvironment. Recruited tumor associated fibroblasts (TAFs) have been identified as central participants in tumor remodeling and structural matrix formation. These cells are often characterized by increased expression of pathology-associated or “activated” fibroblast markers, fibroblast specific protein (FSP) and fibroblast activation protein (FAP); increased expression of markers of aggression and pro-tumorigenic growth factors; and markers of fibrovascularization such as α-smooth muscle actin (α-SMA) and desmin. The origin of TAFs is not well understood, but recent evidence from our lab and others indicate bone marrow derived mesenchymal stem cells (BM-MSC) are a source of TAFs [7], [27]–[29]. BM-MSC have been well characterized for their tropism for inflammatory microenvironments such as wounded tissue and tumors [30]. Within wounded tissue, MSC certainly serve a beneficial role in aiding the healing process, however, the role of MSC within the tumor microenvironment is not quite as clear. In this investigation, we sought to determine the origins of TAFs and vascular stromal elements in the tumor microenvironment. By performing a series of multi-colored bone marrow and adipose tissue transplantations prior to tumor establishment, we were able to quantitate endogenous contributions to these populations as measured by multiple phenotypic markers, and determine the tissue of origin of these cells. Our results demonstrate that bone marrow mesenchyme, potentially as mesenchymal stem cells, is recruited into tumors as FSP+/FAP+ TAFs, whereas the vascular stroma (pericytes and fibrovascular structures) defined by αSMA+/NG2+ TAFs as well as endothelial cells is recruited from neighboring adipose tissue. These data suggest the recruitment of two distinct subpopulations of TAFs each with a discrete tissue of origin. RESULTS Relative contribution of bone marrow-derived vs. local resident tissue in ID8 ovarian tumors In the first set of experiments, bone marrow from GFP expressing mice was transplanted into lethally irradiated RFP mice. Upon engraftment, as evidenced by >95% GFP expression in the peripheral blood and the death of control mice not receiving bone marrow, the mice received ID8 ovarian tumors (Figure S1). Analysis of tumor sections revealed that GFP+ and RFP+ stromal cells (of non-tumor origin) comprised 23+/−3% of cells found within the tumor mass. These cells were found both around the periphery and within the parenchyma of the tumor. Of the stromal cells, 42+/−9% were bone marrow-derived and 58+/−6% were non-bone marrow-derived, representing 10+/−2% and 14+/−1% of the tumor bulk, respectively. Next, we analyzed the tumor sections for phenotypic markers generally associated with tumor associated fibroblasts (TAFs), including αSMA, NG2, FAP and FSP. Interestingly, under our experimental conditions, αSMA and NG2 expression

Read the complete text